IBDEI1GX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26045,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,26045,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,26046,0)
 ;;=307.51^^150^1654^2
 ;;^UTILITY(U,$J,358.3,26046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26046,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,26046,1,5,0)
 ;;=5^Bulemia Nervosa
 ;;^UTILITY(U,$J,358.3,26046,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,26047,0)
 ;;=307.50^^150^1654^3
 ;;^UTILITY(U,$J,358.3,26047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26047,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,26047,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,26047,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,26048,0)
 ;;=333.99^^150^1655^2
 ;;^UTILITY(U,$J,358.3,26048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26048,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,26048,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,26048,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,26049,0)
 ;;=332.0^^150^1655^3
 ;;^UTILITY(U,$J,358.3,26049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26049,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,26049,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,26049,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,26050,0)
 ;;=333.79^^150^1655^1
 ;;^UTILITY(U,$J,358.3,26050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26050,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,26050,1,5,0)
 ;;=5^Acquired Torsion Dystonia NEC
 ;;^UTILITY(U,$J,358.3,26050,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,26051,0)
 ;;=333.85^^150^1655^4
 ;;^UTILITY(U,$J,358.3,26051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26051,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,26051,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,26051,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,26052,0)
 ;;=V87.39^^150^1656^1
 ;;^UTILITY(U,$J,358.3,26052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26052,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,26052,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,26052,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,26053,0)
 ;;=310.0^^150^1657^1
 ;;^UTILITY(U,$J,358.3,26053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26053,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,26053,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,26053,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,26054,0)
 ;;=310.1^^150^1657^3
 ;;^UTILITY(U,$J,358.3,26054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26054,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,26054,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,26054,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,26055,0)
 ;;=310.2^^150^1657^4
 ;;^UTILITY(U,$J,358.3,26055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26055,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,26055,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,26055,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,26056,0)
 ;;=310.81^^150^1657^5
 ;;^UTILITY(U,$J,358.3,26056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26056,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,26056,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,26056,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,26057,0)
 ;;=310.89^^150^1657^2
 ;;^UTILITY(U,$J,358.3,26057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26057,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,26057,1,5,0)
 ;;=5^Mental D/O d/t Brain Damage,Oth Spec
 ;;^UTILITY(U,$J,358.3,26057,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,26058,0)
 ;;=90832^^151^1658^1^^^^1
 ;;^UTILITY(U,$J,358.3,26058,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26058,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,26058,1,3,0)
 ;;=3^Psychotherapy 16-37 min
 ;;^UTILITY(U,$J,358.3,26059,0)
 ;;=90834^^151^1658^2^^^^1
 ;;^UTILITY(U,$J,358.3,26059,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI1GX
